InvestorsHub Logo
Followers 511
Posts 59399
Boards Moderated 4
Alias Born 12/21/2009

Re: FooBarAndGrill post# 832

Tuesday, 10/31/2023 12:23:42 PM

Tuesday, October 31, 2023 12:23:42 PM

Post# of 878
Posted yesterday about the Conference call…..

The Carson City, Nev.-based clinical-stage pharmaceutical company said Monday morning it would host a conference call Nov. 1 to discuss the blinded data on its Phase 3 clinical trial of NE3107 in the treatment of mild to moderate Alzheimer's.

Registration details are as follows:
Date November 1, 2023
Time 8:00 AM Eastern Time
Conference Call Details 1-877-407-3982 (U.S. Investors Dial-in)

1-201-493-6780 (International Investors Dial-in)

13742478 (Conference ID Code)

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BIVI News